Drug Discovery & Development

Strategies & Technologies Driving Drug Discovery to Market

Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

ALA Names Innovation Award Finalists

January 14, 2008 7:41 am | News | Comments

The Association for Laboratory Automation (ALA) announced the finalists for its $10,000 Innovation Award, which recognizes outstanding innovation and contributions to automation technologies in the laboratory.

TOPICS:

Menveo Shown to Provide Immunogenicity

January 14, 2008 7:08 am | News | Comments

Menveo, a vaccine in development by Novartis, may protect infants using a schedule beginning at two months of age against four of the most common causes of meningococcal disease.

TOPICS:

Takeda Submits New Drug Application for Alogliptin

January 14, 2008 6:58 am | News | Comments

Takeda Global Research & Development Center submitted a New Drug Application to the FDA for alogliptin, a highly selective dipeptidyl peptidase-4 inhibitor under investigation for the treatment of type 2 diabetes.

TOPICS:
Advertisement

Oncolytics Biotech Files Phase 1/2 Clinical Trial

January 14, 2008 6:50 am | News | Comments

The U.S. National Cancer Institute has filed a protocol for a Phase 1/2 clinical trial for patients with metastatic ovarian, peritoneal, or fallopian tube cancers using concurrent systemic and intraperitoneal administration of Reolysin, Oncolytics Biotech's’ formulation of the human reovirus.

TOPICS:

Automation Oasis

January 14, 2008 6:50 am | Articles | Comments

LabAutomation2008 Show Preview  Scientists and technology will converge in the desert at LabAutomation2008 to explore the latest in automation,  high-throughput technologies, informatics, and more.

Fluorescence Detection

January 14, 2008 6:19 am | Product Releases | Comments

The XLC-3020FP fluorescence detector provides a signal-to-noise ratio with stability over a wide wavelength range (220-700 nm) for both excitation and emission.

TOPICS:

HPLC Columns

January 14, 2008 6:13 am | Product Releases | Comments

Scientists from Supelco, a member of the Sigma-Aldrich group, have effectively extended the use of high-resolution LC by exceeding 120,000 plates/column under moderate operating conditions using commercial instrumentation.

TOPICS:

Sample Prep Prior to HPLC or GC

January 14, 2008 5:54 am | Product Releases | Comments

Phenomenex Inc. introduces a new support and reference tool that helps chromatographers develop and optimize solid phase extraction (SPE) sample preparation methods.

TOPICS:
Advertisement

Scientists Identify New Genetic Link to Autism

January 11, 2008 10:47 am | News | Comments

A team from UCLA discovered that a gene linked to autism is most active in brain regions involved with language and thought.

TOPICS:

Common Molecule Notifies Immune System of Prostate Cancer

January 11, 2008 10:01 am | News | Comments

In experiments with mice, researchers have found that the body's immune system can use a surprisingly common molecule to recognize prostate tumors.

TOPICS:

RNA Shown to Silence Cancer Suppressor Gene

January 11, 2008 9:53 am | News | Comments

Researchers at Johns Hopkins have discovered that at least one tumor suppressor gene is in fact turned off by a “noncoding” single stranded RNA nucleic acid similar to its double-stranded DNA cousin.

TOPICS:

FDA Approves Only 19 New Drugs in 2007

January 11, 2008 4:52 am | News | Comments

FDA approved 19 new medications in 2007, a decrease from 22 in 2006 and the lowest number since 1983.

TOPICS:

Knocked Down or Out ???

January 10, 2008 4:32 pm | by Ashok Patel, Senior Research Fellow, University Institute of Chemical Technology, Mumbai, India | Articles | Comments

Antisense therapy has been on a roller coaster ride since its inception. Is this heavyweight really down for the count?

TOPICS:

Tools of the Trade

January 10, 2008 4:13 pm | by Marina Bibikova, PhD and Jian-Bing Fan, PhD, Illumina, San Diego, Calif. | Articles | Comments

Epigenetic changes are rapidly gaining acceptance as co-conspirators in carcinogenesis fueling the demand for DNA methylation assays.

TOPICS:

Where Were You in 1998?

January 10, 2008 11:09 am | by Rita C. Peters, Editor In Chief | Articles | Comments

As Drug Discovery & Development enters its second decade of publishing, we reflect on the future and offer thanks to researchers working in the trenches.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading